Arrivo BioVentures
Phase 1ARRIVO has a portfolio of diverse late-stage drug candidates through partnering with investors, innovators, and pharmaceutical companies.
Founded
2018
Focus
BiologicsSmall Molecules
About
ARRIVO has a portfolio of diverse late-stage drug candidates through partnering with investors, innovators, and pharmaceutical companies.
Funding History
3Total raised: $90.3M
Series B$45.3MUndisclosedNov 29, 2023
Series A$35MFrazier Life SciencesNov 15, 2022
Seed$10MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2018
LocationRaleigh, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile